This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

One hundred and fifty-six scientists have just published a long letter in various journals explaining why we need to continue with Gain of Function...

Inaugural International Recurrent Respiratory Papillomatosis Awareness Day